Doctor Cautious On Drug (Press, 22 September 1986)
This is a Generative AI summary of this newspaper article. It may contain errors or omissions. Please note that the language in the summary is reflective of the original article and the societal attitudes of the time in which it was written.
Summary: Doctor Cautious On Drug (Press, 22 September 1986)
Dr Ellis Pegler, an infectious diseases specialist at an Auckland Hospital, expressed caution regarding the claims made about the new drug AZT for treating A.I.D.S. patients in the United States. He stated that his knowledge of the drug's clinical results was limited to what had been presented on television over the weekend, and he highlighted the importance of reviewing trial data before making any decisions about its availability for patients in Auckland. Dr Pegler acknowledged the potential pressure he might face from patients seeking access to AZT but emphasised that there have been previous instances of drugs claiming significant benefits for A.I.D.S. treatment that ultimately proved ineffective. He mentioned that he would be attending an international chemotherapy conference in New Orleans in the near future, where he anticipated that trial data on AZT would be presented to a medical audience.
Important Information
The text on this page is created, in the most part, using Generative AI and so may contain errors or omissions. It is supplied to you without guarantee or warranty of correctness. If you find an error or would like to make a content suggestion please get in contact
The text on this page is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 New Zealand